ARMISTICE CAPITAL LLC 13D and 13G filings for Enveric Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:03 pm Sale |
2024-09-30 | 13G | Enveric Biosciences, Inc. ENVB |
ARMISTICE CAPITAL LLC | 0 0.000% |
-1,214 (Position Closed) |
Filing |
| 2024-02-14 3:36 pm Purchase |
2023-12-31 | 13G | Enveric Biosciences, Inc. ENVB |
ARMISTICE CAPITAL LLC | 1,214 9.990% |
1,214 (New Position) |
Filing |